Related Experiment Video
Updated: Jan 23, 2026
09:38
Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
943
Management of invasive melanoma
Anthony J Dixon1, Howard K Steinman2, Alexander Nirenberg3
1PhD, MBBS, FACRRM, MAOCD, Director of Education, Australasian College of Cutaneous Oncology, Docklands, Vic; Honorary Professor, American Osteopathic College of Dermatology, Kirksville, Missouri, USA.
Australian Journal of General Practice
|June 21, 2019
Summary
Early diagnosis and ideal management are crucial for invasive melanoma survival. This study identifies common, suboptimal aspects in melanoma patient care, highlighting areas for improvement in diagnosis and treatment strategies.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Maximizing survival in invasive melanoma relies on early detection and optimal management.
- Despite established guidelines, many melanoma patients receive suboptimal care.
Purpose of the Study:
- To identify and analyze suboptimal practices in the management of invasive melanoma.
Main Methods:
- Review of diagnostic and management strategies for primary melanoma.
- Analysis of factors influencing patient outcomes, including biopsy techniques and prognostic indicators.
Main Results:
- Shave or punch biopsies increase the risk of delayed or incorrect diagnosis.
- Local excision with narrow margins is the preferred initial biopsy for suspected melanoma.
- Breslow thickness and ulceration are key prognostic factors; patients with a history of melanoma have a high risk for secondary tumors.
Conclusions:
- Improving melanoma management requires addressing diagnostic delays and optimizing treatment protocols.
- Lifelong skin surveillance and UV exposure reduction are essential for high-risk patients.
- Judicious use of imaging for suspected metastases is recommended.
Related Concept Videos
01:29Impression Management Techniques I: Managing Appearances
205
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
205
01:26Tonsillitis II: Management
412
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
412
01:19Management of Insomnia
560
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
560
01:19Managing Impressions
165
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
165
01:24Cystic Fibrosis: Management
485
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
485
01:26Angina IV: Management
253
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
253